Form 4: Director Gregory Lucier Executes Internal Stock Transfers

Sentiment:

Statement of Changes in Beneficial Ownership


Dentsply Sirona Director Gregory Lucier reported the acquisition and subsequent transfer of equity and options to a family partnership.

Summary

  • Director Gregory Lucier received a grant of 38,382 Restricted Stock Units (RSUs) on June 3, 2026.
  • The director simultaneously transferred these 38,382 RSUs to a family partnership.
  • A grant of 10,900 stock options with an exercise price of $9.64 was also received and transferred to the same family partnership.
  • The transactions reflect a shift in beneficial ownership to a family partnership structure rather than an open-market sale or purchase.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transactions represent internal estate planning rather than a change in the director's confidence in the company.

Positives

  • The director maintains a significant economic interest in the company through direct and indirect holdings.
  • The transaction structure indicates long-term estate or family wealth planning rather than a divestment of interest.

Negatives

  • The filing reflects internal movement of assets rather than new market-based investment activity.

Risks

  • The reporting person disclaims beneficial ownership of the transferred securities, which may complicate future reporting of his total pecuniary interest.

Future Outlook

The RSUs and stock options are subject to a one-year vesting period, with the options expiring on June 3, 2036.

Industry Context

StockSavvy.ai notes that internal transfers of equity to family partnerships are common among corporate directors for estate planning purposes and generally do not signal a change in sentiment regarding the company's operational performance.

Comparison to Industry Standards

  • The use of family partnerships for holding equity is a standard practice among high-net-worth corporate directors in the S&P 500.
  • The vesting schedule of one year for RSUs and options is consistent with standard executive compensation packages in the medical device industry.

Related Party Transactions

  • The reporting person transferred securities to a family partnership where his spouse serves as the general partner.

Stakeholder Impact

  • Minimal impact on shareholders as the director retains an indirect interest in the securities.

Next Steps

  • Vesting of RSUs on June 3, 2027.
  • Vesting of stock options on June 3, 2027.

Key Dates

DateDescription
06/03/2026Date of RSU grant, option grant, and subsequent transfers to family partnership.
06/05/2026Date of filing signature.

Keywords

Dentsply Sirona, XRAY, Insider Trading, Form 4, Gregory Lucier, Restricted Stock Units, Stock Options

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.